When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HEPA - Hepion Pharma up 15% premarket potential of CRV431 in NASH
Hepion Pharmaceuticals Inc.
Nano cap Hepion Pharmaceuticals (NASDAQ:HEPA) is up 15% premarket on modest volume on the heels of a just-published paper supporting the rationale of cyclophilin inhibition for the potential treatment of nonalcoholic steatohepatitis (NASH).
More news on: Hepion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,